Key facts
- Notable investors include rpv, Altitude Lab, Nucleus Fund.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Intactis Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Intactis Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Intactis Bio
Developer of tissue culture equipment intended to revolutionize biocomputation and regenerative medicine. The company offers tissue-engineered regenerative medicine and large-scale biocomputation, enabling the biotechnology industry to achieve long-term tissue viability at clinically relevant scales at reduced cost.
- Sector
- Healthcare
- HQ
- Salt Lake City, UT, United States
- Founded
- 2024
- Employees
- 5
- Website
- intactis.bio/
- Ownership
- Privately Held (backing)
Intactis Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Intactis Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Intactis Bio in its N-PORT filings yet. We sweep new filings monthly.